Vincenza Valerio
Overview
Explore the profile of Vincenza Valerio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Myasoedova V, Ravani A, Frigerio B, Moschetta D, Valerio V, Massaiu I, et al.
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768265
Background: Ageing is a significant risk factor for carotid atherosclerosis, affecting over a billion people worldwide. Carotid intima-media thickness (cIMT) is a surrogate marker for cardiovascular disease (CVD) risk, with...
2.
Myasoedova V, Bertolini F, Valerio V, Moschetta D, Massaiu I, Rusconi V, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335491
Background: Fibro-calcific aortic valve disease (FCAVD) is a progressive disorder characterized by the thickening and calcification of the aortic valve, eventually leading to aortic stenosis. Adiponectin and leptin, known for...
3.
Myasoedova V, Rega S, Valerio V, Moschetta D, Massaiu I, Bonalumi G, et al.
Front Pharmacol
. 2024 Aug;
15:1426982.
PMID: 39148550
Aims: Thoracic aortic aneurysm (TAA) that progress to acute aortic dissection is often fatal and there is no pharmacological treatment that can reduce TAA progression. We aim to evaluate statins'...
4.
Myasoedova V, Chiesa M, Cosentino N, Bonomi A, Ludergnani M, Bozzi M, et al.
Eur J Prev Cardiol
. 2024 Feb;
PMID: 38365224
Background: Patients with acute myocardial infarction (AMI) are at increased risk of recurrent cardiovascular events. Non-stenotic aortic valve fibro-calcific remodeling (AVSc), reflecting systemic damage, may serve as a new marker...
5.
Myasoedova V, Bozzi M, Valerio V, Moschetta D, Massaiu I, Rusconi V, et al.
Antioxidants (Basel)
. 2024 Jan;
13(1).
PMID: 38275636
Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists...
6.
Conte M, Poggio P, Monti M, Petraglia L, Cabaro S, Bruzzese D, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256243
Amyloid deposition within stenotic aortic valves (AVs) also appears frequent in the absence of cardiac amyloidosis, but its clinical and pathophysiological relevance has not been investigated. We will elucidate the...
7.
Piacentini L, Myasoedova V, Chiesa M, Vavassori C, Moschetta D, Valerio V, et al.
Arterioscler Thromb Vasc Biol
. 2023 Dec;
44(2):452-464.
PMID: 38126173
Background: Aortic valve sclerosis (AVSc) presents similar pathogenetic mechanisms to coronary artery disease and is associated with short- and long-term mortality in patients with coronary artery disease. Evidence of AVSc-specific...
8.
Massaiu I, Campodonico J, Mapelli M, Salvioni E, Valerio V, Moschetta D, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769209
In heart failure, the biological and clinical connection between abnormal iron homeostasis, myocardial function, and prognosis is known; however, the expression profiles of iron-linked genes both at myocardial tissue and...
9.
Myasoedova V, Parisi V, Moschetta D, Valerio V, Conte M, Massaiu I, et al.
Cardiovasc Diabetol
. 2023 Feb;
22(1):23.
PMID: 36721184
Background: Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and could be a potential therapeutic target for drugs that already show...
10.
Conte M, Petraglia L, Cabaro S, Valerio V, Poggio P, Pilato E, et al.
Front Cardiovasc Med
. 2022 Jul;
9:932262.
PMID: 35845044
Atrial Fibrillation (AF) is the most frequent cardiac arrhythmia and its prevalence increases with age. AF is strongly associated with an increased risk of stroke, heart failure and cardiovascular mortality....